EcoR1 Capital, LLC
Top Portfolio Positions
28 positions ·
$2,359,197,078 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| ZYME |
Zymeworks Inc.
Healthcare
|
22,970,388 | $575,178,515 | 24.38% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
7,880,094 | $437,030,013 | 18.52% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
1,706,469 | $322,607,964 | 13.67% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
6,410,800 | $254,636,976 | 10.79% | |
| CRNX |
Crinetics Pharmaceuticals, Inc.
Healthcare
|
4,288,120 | $155,744,518 | 6.60% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
4,824,469 | $86,309,750 | 3.66% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
6,728,116 | $85,245,229 | 3.61% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
1,102,000 | $74,583,360 | 3.16% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
1,389,276 | $66,087,859 | 2.80% | |
| ETON |
Eton Pharmaceuticals, Inc.
Healthcare
|
2,171,938 | $53,603,429 | 2.27% |
Portfolio Trend
25 quarters · across all stocks
Holdings in PCVX
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $20,763,000 | 450,000 | Shares | Sole | 2026-02-17 | |
| 2024-09-30 | $40,276,061 | 352,464 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,653,000 | 300,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,493,000 | 300,000 | Shares | Sole | 2024-05-15 | |
| 2022-03-31 | $31,509,495 | 1,304,741 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $494,832 | 20,800 | Shares | Sole | 2022-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||